DYN — Dyne Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapMomentum Trap

Annual balance sheet for Dyne Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	14.6	345	377	256	123
Prepaid Expenses
Total Current Assets	14.8	349	382	266	129
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.49	1.95	41	38.4	33.4
Other Long Term Assets
Total Assets	16.4	353	426	306	165
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	2.36	11	28.7	28.1	51.1
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	2.4	11	57.5	54	73.8
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	14	342	368	252	91.3
Total Liabilities & Shareholders' Equity	16.4	353	426	306	165
Total Common Shares Outstanding